E
Eliel Bayever
Researcher at Janssen Pharmaceutica
Publications - 33
Citations - 1427
Eliel Bayever is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Irinotecan & Gemcitabine. The author has an hindex of 12, co-authored 30 publications receiving 1154 citations. Previous affiliations of Eliel Bayever include Children's Hospital of Philadelphia.
Papers
More filters
Journal ArticleDOI
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang-Gillam,Chung-Pin Li,György Bodoky,Andrew Dean,Yan Shen Shan,Gayle S. Jameson,Teresa Macarulla,Kyung-Hun Lee,David Cunningham,Jean F Blanc,Richard A Hubner,Chang Fang Chiu,Gilberto Schwartsmann,Jens T. Siveke,Fadi Braiteh,Victor Moyo,Bruce Belanger,Navreet Dhindsa,Eliel Bayever,Daniel D. Von Hoff,Li-Tzong Chen,Li-Tzong Chen +21 more
TL;DR: Nanoliposomal irinotecan in combination with fluorouracil and folinic acid extends survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma who previously received gemcitabine-based therapy.
Journal ArticleDOI
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
Ramesh K. Ramanathan,Ronald L. Korn,Natarajan Raghunand,Jasgit C. Sachdev,Ronald G. Newbold,Gayle S. Jameson,Gerald J. Fetterly,Joshua Prey,Stephan G. Klinz,Jaeyeon Kim,Jason E. Cain,Bart S. Hendriks,Daryl C. Drummond,Eliel Bayever,Jonathan Fitzgerald +14 more
TL;DR: Correlation between FMX levels in tumor lesions and nal-IRI activity suggests that lesion permeability to FMX and subsequent tumor uptake may be a useful noninvasive and predictive biomarker for nal -IRI response in patients with solid tumors.
Journal ArticleDOI
The status of hematopoietic stem cell transplantation in lysosomal storage disease
TL;DR: Hematopoietic stem cell transplantation remains a viable treatment option in those lysosomal storage diseases where data supportive of disease stabilization or amelioration are known.
Journal ArticleDOI
Hurler syndrome with special reference to histologic abnormalities of the growth plate.
Christopher P. Silveri,Frederick S. Kaplan,Michael D. Fallon,Eliel Bayever,Charles S. August +4 more
TL;DR: Histochemical and electron-microscopic observations on a 30-month-old child with Hurler syndrome showed marked irregularities in chondrocyte orientation within the growth plate, along with disruption of the normal columnar architecture.
Journal ArticleDOI
O-0003napoli-1: randomized phase 3 study of mm-398 (nal-iri), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer progressed on or following gemcitabine-based therapy
D. D. Von Hoff,C.-P. Li,Andrea Wang-Gillam,G. Bodoky,Andrew Dean,Gayle S. Jameson,Teresa Macarulla,Kiheon Lee,David Cunningham,Jean-Frédéric Blanc,Richard A. Hubner,Chang Fang Chiu,Gilberto Schwartsmann,Jens T. Siveke,F. Braiteh,Victor Moyo,Bruce Belanger,Navreet Dhindsa,Eliel Bayever,L.-T. Chen +19 more